|
TOR1B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.68350000000683E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.003260E-04 |
| Normal-vs-Stage2 |
9.462400E-02 |
| Normal-vs-Stage3 |
2.08639999998983E-06 |
| Normal-vs-Stage4 |
5.88669999967983E-07 |
| Stage1-vs-Stage2 |
2.813200E-01 |
| Stage1-vs-Stage3 |
1.163970E-01 |
| Stage1-vs-Stage4 |
3.132000E-02 |
| Stage2-vs-Stage3 |
5.074200E-02 |
| Stage2-vs-Stage4 |
1.905520E-02 |
| Stage3-vs-Stage4 |
4.387800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.92889999994783E-06 |
| Normal-vs-AfricanAmerican |
3.555800E-02 |
| Normal-vs-Asian |
1.022770E-03 |
| Caucasian-vs-AfricanAmerican |
4.927400E-01 |
| Caucasian-vs-Asian |
5.780800E-01 |
| AfricanAmerican-vs-Asian |
7.467400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.28460000001518E-06 |
| Normal-vs-Female |
7.87790000000843E-05 |
| Male-vs-Female |
3.141400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.169260E-04 |
| Normal-vs-Age(41-60Yrs) |
2.23480000000054E-05 |
| Normal-vs-Age(61-80Yrs) |
4.195800E-04 |
| Normal-vs-Age(81-100Yrs) |
2.223800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.125600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.092400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.943200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.012000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.053000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.376600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.320200E-02 |
| Classical-VS-Follicular |
9.831400E-01 |
| Classical-VS-Other |
6.080000E-01 |
| Classical-VS-Normal |
1.644500E-04 |
| Tall-VS-Follicular |
5.593600E-02 |
| Tall-VS-Other |
5.968200E-01 |
| Tall-VS-Normal |
3.08520000003032E-06 |
| Follicular-VS-Other |
6.789000E-01 |
| Follicular-VS-Normal |
2.264300E-03 |
| Other-VS-Normal |
3.887800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.608860E-04 |
| Normal-vs-N1 |
1.18579999996982E-06 |
| N0-vs-N1 |
3.830000E-02 |
|
|
